Mayo study CT site update

[biopearl]

Last patient follow up now scheduled for 2019. Top line data still on for May 2017. This change implies an ongoing longevity effect to me. bp

[biotech_bs]

Makes sense. Imetelstat will be on the market (hopefully) by 2019 so these patients can continue treatment. This should be good news for irishtrader's husband.

[irishtrader52]

Yes. All good news for irishtrader spouse. We never doubted JJ will extend treatment as long as needed and it is working until day of happy approval. This is our red letter day! The day John does not have to travel 2000 miles every 3 weeks for treatement. Robs a lot of valuable time that is a wasting and causes us to live in 3/4 time. So we await the glorious day he can get in the car and drive 20 minutes down the road for 2 hour infusion. He says he flies more now than when he was in the Army. He departs again for RST tomorrow 7:00 am. We see light at end of very long dark tunnel. I think 2019 outside boundary so don't have to keep revising study protocol while approval evolves into implementation. From FDA paperwork to an infusion center near you. Staying alive.